Quote this publication Share Print

VOLTARENDOLO

-
Opinions on drugs - Posted on May 16 2014

Reason for request

Re-assessment of the Actual Benefit of all medicines based on

-


Clinical Benefit

Substantial

The actual benefit of this proprietary medicinal product in this indication remains substantial.

Insufficient

The actual benefit of this proprietary medicinal product in this indication remains insufficient in the sub-population of patients with risk factors for a cardiovascular event.